Alterity Therapeutics
ATHE
26 hedge funds and large institutions have $1.75M invested in Alterity Therapeutics in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.
55% more call options, than puts
Call options by funds: $709K | Put options by funds: $457K
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
20% less capital invested
Capital invested by funds: $2.2M → $1.75M (-$447K)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
+$183K |
| 2 |
Morgan Stanley
New York
|
+$31.8K |
| 3 |
GA
Geneva Advisors
Chicago,
Illinois
|
+$24.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$19.4K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$12.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$130K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$119K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$88.8K |
| 4 |
Jane Street
New York
|
-$78K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$72K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Group One Trading
Chicago,
Illinois
| – | -$130K | -971 | Closed |
|
|
27
Verition Fund Management
Greenwich,
Connecticut
| – | -$119K | -881 | Closed |
|
|
28
Citadel Advisors
Miami,
Florida
| – | -$72K | -528 | Closed |
|
|
CS
29
Credit Suisse
Zurich,
Switzerland
| – | -$65K | -481 | Closed |
|
|
NCCM
30
Nine Chapters Capital Management
Short Hills,
New Jersey
| – | -$36K | -265 | Closed |
|
ATHE Hedge Fund Activity: Q3 2014 in Review
26 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2014, worth a combined $1.75M — down 20% from $2.2M a quarter earlier.
Fund positioning in ATHE was balanced in Q3 2014: 5 funds opened new positions, 5 closed out, 5 added to existing stakes and 8 trimmed.
The largest buyer was A.R.T. Advisors, opening a new position worth an estimated $183K. The largest seller was Group One Trading, exiting entirely with an estimated $130K sold.
- 26 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $1.75M of Alterity Therapeutics stock for Q3 2014, down 20% quarter-over-quarter.
- 5 funds opened new Alterity Therapeutics positions in Q3 2014 and 5 closed out, a net change of 0 holders.
- The largest Alterity Therapeutics buyer in Q3 2014 was A.R.T. Advisors, an estimated $183K added.
- The largest Alterity Therapeutics seller in Q3 2014 was Group One Trading, an estimated $130K sold.
Based on aggregated 13F filings for Q3 2014.